Buy back

Buyback Premium Above 10pctCorporate Actions View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.9%1-day move

₹992.00

prior close

₹1037.25

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.4+0.7+0.1+0.3+4.9+4.5+4.7+8.0+8.6+9.1+10.6+8.1+15.8—

Up moveDown movePending

AI summary

Zydus Lifesciences Ltd's Board has approved a buyback of up to 95,65,217 fully paid-up equity shares (0.95% of total paid-up capital) at INR 1,150 per share. The total buyback size is INR 1,100 crores, representing 5.16% and 3.84% of standalone and consolidated free reserves respectively. The buyback will be conducted via the tender offer route, open to all equity shareholders including promoters on a proportionate basis. The record date for determining eligible shareholders is May 29, 2026. A buyback committee has been formed to oversee the process. Pre-buyback shareholding shows promoters hold 74.995% of the company.

Likely market impact

The buyback offers shareholders a chance to exit at INR 1,150 per share, which is significantly above the current market price, providing a positive signal for stock price support near that level. This is a shareholder-friendly move returning capital while potentially enhancing per-share metrics.